Nobiletin reduced ACSL4 and NCOA4 expression and inhibited the effect of Erastin or oe-ACSL4 in increasing ACSL4 expression. Alleviation of myocardial ischemia–reperfusion injury in T2DM rats. Here, NCOA4 is linked to type 2 diabetes mellitus.